Botulinum Toxin Type A for the Management of Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) was a chronic, recurrent inflammatory skin disease affecting hair follicles, often presenting as painful lesions in areas with many apocrine glands. The disease's management was challenging, with treatments like antibiotics, retinoids, biologics, and surgery showing variable efficacy. Recent reports indicated that botulinum toxin type A injections had a positive effect on managing HS. This review explored the pathogenesis, clinical manifestations, and traditional treatments of HS, while also investigating botulinum toxin type A as a potential treatment option.